The United Laboratories International Holdings Limited (ULIHF)

Market Cap	3.55B
Revenue (ttm)	1.89B
Net Income (ttm)	364.39M
Shares Out	n/a
EPS (ttm)	0.20
PE Ratio	9.75
Forward PE	8.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	1
Open	1.500
Previous Close	1.400
Day's Range	1.400 - 1.500
52-Week Range	0.893 - 2.350
Beta	0.11
RSI	33.77
Earnings Date	May 29, 2025

About ULIHF

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: ULIHF

Financial Performance

In 2024, ULIHF's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY